ADVERTISEMENT
On display for Dutch delegation in Bengaluru: From wearables to molecules The startup Dozee, for instance, presented its AI-based early warning and remote patient monitoring system, which generates 500 data points per second to track patient condition changes.
Udbhavi Balakrishna
Last Updated IST
<div class="paragraphs"><p>Barbara Goezinne, the Netherlands’ Vice Minister of Health, Curative Care, and her delegation with Karnataka Health Minister Dinesh Gundu Rao at Bengaluru’s Centre for Cellular and Molecular Platforms (C-CAMP) on Thursday. </p></div>

Barbara Goezinne, the Netherlands’ Vice Minister of Health, Curative Care, and her delegation with Karnataka Health Minister Dinesh Gundu Rao at Bengaluru’s Centre for Cellular and Molecular Platforms (C-CAMP) on Thursday.

Credit: C-CAMP  

Bengaluru: Innovators supported by C-CAMP showcased their AI-powered health tech products to the Dutch delegation led by Barbara Goezinne, Vice Minister of Health, Curative Care, the Netherlands.

ADVERTISEMENT

These products included solutions for remote patient monitoring, wearables to detect heartbeat anomalies, portable EEGs, and an oral hygiene management system for critical care patients.

These innovations, supported or incubated by C-CAMP, sparked significant interest among the Dutch delegation.

The startup Dozee, for instance, presented its AI-based early warning and remote patient monitoring system, which generates 500 data points per second to track patient condition changes.

Another company, Cardiac Design Labs, displayed a wearable patch for arrhythmia detection, with all components reportedly made in India. This product is awaiting CE certification for European sales. Their other product, which identifies blood pressure trends, is currently used in ICUs across India.

Trana Labs, another of the city-based biotech startup, highlighted its development of three molecules for macrophage-targeted delivery for Gaucher Disease, claiming a two-fold improvement over current treatments. They are also collaborating with IIT Kanpur and IISER Tirupati to develop dengue antivirals and antibiotics, which are currently undergoing testing.

InnAccel showcased its patented oral hygiene management system, which is slated for pilot programmes in the US and the UK. They also presented a non-invasive neonatal and paediatric respiratory support machine, for which they have received a 90-unit order from the Karnataka government.

ADVERTISEMENT
(Published 28 March 2025, 01:22 IST)